Similar articles

• Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma.

  Jehanne M, Lumbroso-Le Rouic L, Savignoni A, Aerts I, Mercier G, Bours D, Desjardins L, Doz F. Jehanne M, et al. Pediatr Blood Cancer. 2009 May;52(5):637-43. doi: 10.1002/pbc.21898. Pediatr Blood Cancer. 2009. PMID: 19148943
• Monitoring of ototoxicity in young children receiving carboplatin for retinoblastoma.

  Jehanne M, Mercier G, Doz F. Jehanne M, et al. Pediatr Blood Cancer. 2009 Dec;53(6):1162. doi: 10.1002/pbc.22124. Pediatr Blood Cancer. 2009. PMID: 19479791 No abstract available.
• Monitoring carboplatin ototoxicity with distortion-product otoacoustic emissions in children with retinoblastoma.

  Bhagat SP, Bass JK, White ST, Qaddoumi I, Wilson MW, Wu J, Rodriguez-Galindo C. Bhagat SP, et al. Int J Pediatr Otorhinolaryngol. 2010 Oct;74(10):1156-63. doi: 10.1016/j.ijporl.2010.07.004. Epub 2010 Jul 29. Int J Pediatr Otorhinolaryngol. 2010. PMID: 20667604 Free PMC article. Clinical Trial.
• Assessment of hearing in very young children receiving carboplatin for retinoblastoma.

  Smits C, Swen SJ, Theo Goverts S, Moll AC, Imhof SM, Schouten-van Meeteren AY. Smits C, et al. Eur J Cancer. 2006 Mar;42(4):492-500. doi: 10.1016/j.ejca.2005.11.004. Epub 2006 Jan 11. Eur J Cancer. 2006. PMID: 16376542 Review.
• Understanding platinum-induced ototoxicity.

  Langer T, am Zehnhoff-Dinnesen A, Radtke S, Meitert J, Zolk O. Langer T, et al. Trends Pharmacol Sci. 2013 Aug;34(8):458-69. doi: 10.1016/j.tips.2013.05.006. Epub 2013 Jun 13. Trends Pharmacol Sci. 2013. PMID: 23769626 Review.